[1]
2026. Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study. Archivio Italiano di Urologia e Andrologia. (Aug. 2026). DOI:https://doi.org/10.4081/aiua.2026.15630.